DelveInsight has launched a new report on“Alopecia Areata – Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Alopecia Areata – Market Insights, Epidemiology, and Market Forecast-2030″report delivers an in-depth understanding of the Alopecia Areata, historical and forecasted epidemiology as well as the Alopecia Areata market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Report:
According to the Foundation, approximately 6.8 million people in the United States and 147 million worldwide have or will develop alopecia areata at some point in their lives.
As per the study patients with AA experience their first onset of AA by age 40 years in 82.6–88% of patients and by age 20 years in 40.2% of patients. The mean age of onset has been reported as between 25.2 and 36.3 years. In children, the mean age of onset has been reported as between ages 5 and 10 years.
In one study of 736 patients, a male-to-female ratio of 1:1 was reported. In another study on a smaller number of patients, a slight female preponderance was seen. [Chantal Bolduc et al., 2018]
Key benefits of the report:
Alopecia Areata market report covers a descriptive overview and comprehensive insight of the Alopecia Areata epidemiology and Alopecia Areata market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Alopecia Areata market report provides insights on the current and emerging therapies.
Alopecia Areata market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Alopecia Areata market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Alopecia Areata market.
Got queries? Click here to know more about Alopecia Areata Market Landscape.
Alopecia Areata Overview
Alopecia areata is a condition that causes hair to fall out in small patches, which can be unnoticeable. These patches may connect, however, and then become noticeable. The condition develops when the immune system attacks the hair follicles, resulting in hair loss.
The key players involved in the Alopecia Areata market:
Legacy Healthcare SA
Suzhou Zelgen Biopharmaceuticals
Eli Lilly, and Company/Incyte Corporation
The launch of the emerging therapies is expected to significantly impact the Alopecia Areata treatment scenario in the upcoming years:-
PF-06651600 and PF-06700841
Jaktinib hydrochloride tablets
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Alopecia Areata Patient Share (%) Overview at a Glance
5. Alopecia Areata Market Overview at a Glance
6. Alopecia Areata Disease Background and Overview
7. Alopecia Areata Epidemiology and Patient Population
8. Country-Specific Patient Population of Alopecia Areata
9. Alopecia Areata Current Treatment and Medical Practices
10. Unmet Needs
11. Alopecia Areata Emerging Therapies
12. Alopecia Areata Market Outlook
13. Country-Wise Alopecia Areata Market Analysis (2017–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
18. Alopecia Areata Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
“Alopecia Areata Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Alopecia Areata market. A detailed picture of the Alopecia Areata pipeline landscape is provided, which includes the disease overview and Alopecia Areata treatment guidelines.
DelveInsight’s ‘Alopecia Areata Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Alopecia Areata epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States